PRESS RELEASE published on 02/11/2025 at 12:30, 11 months 18 days ago NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape NanoViricides, Inc. declares readiness to combat bird flu with broad-spectrum antiviral drug NV-387. Scientific discussion on virus mutations and potential effectiveness against H5N1. Focus on Trump administration's response NV-387 NanoViricides Inc. Antiviral Drug H5N1 Bird Flu
BRIEF published on 01/29/2025 at 12:35, 1 year ago NanoViricides to Present at MicroCap Conference 2025 NanoViricides NV-387 Microcap Conference Clinical Trials Antiviral Drug
BRIEF published on 01/29/2025 at 12:35, 1 year ago NanoViricides sera présenté à la conférence MicroCap 2025 NanoViricides NV-387 Essais Cliniques Conférence MicroCap Médicament Antiviral
PRESS RELEASE published on 01/29/2025 at 12:30, 1 year ago NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025 NanoViricides, Inc. presents its groundbreaking broad-spectrum antiviral drug NV-387 at MicroCap Conference 2025, showing promising results against various viral infections NanoViricides NV-387 Microcap Conference Antiviral Drug Viral Infections
BRIEF published on 01/27/2025 at 12:35, 1 year ago NanoViricides Advances NV-387 to Phase II Clinical Trial NanoViricides NV-387 Clinical Trial Antiviral Drug MPOX Treatment
BRIEF published on 01/27/2025 at 12:35, 1 year ago NanoViricides fait passer le NV-387 à l'essai clinique de phase II NanoViricides NV-387 Essai Clinique Médicament Antiviral Traitement MPox
PRESS RELEASE published on 01/27/2025 at 12:30, 1 year ago NanoViricides Engages CRO for Phase II Clinical Trial NanoViricides, Inc. engages a Clinical Research Organization for Phase II trial of broad-spectrum antiviral drug NV-387 targeting MPox virus infection. Drug aims to combat viral diseases effectively NanoViricides NV-387 Clinical Trial Antiviral Drug Mpox Virus
BRIEF published on 01/13/2025 at 12:35, 1 year ago NanoViricides to Present Breakthrough Antiviral Developments at Biotech Showcase NanoViricides NV-387 Biotech Showcase Clinical Trials Antiviral Drugs
BRIEF published on 01/13/2025 at 12:35, 1 year ago NanoViricides présentera ses avancées antivirales révolutionnaires au Biotech Showcase NanoViricides NV-387 Essais Cliniques Médicaments Antiviraux Vitrine Biotechnologique
PRESS RELEASE published on 01/13/2025 at 12:30, 1 year ago NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 NanoViricides, Inc. to present Phase II-ready drug NV-387 at Biotech Showcase 2025 in San Francisco, demonstrating broad-spectrum antiviral activity against various infections NV-387 NanoViricides Inc. Antiviral Drug San Francisco Biotech Showcase 2025
Published on 02/02/2026 at 00:05, 3 hours 56 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 2 days ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days 2 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/02/2026 at 02:50, 1 hour 11 minutes ago Xinhua Silk Road: Ecosystem and sustainability redefine global automotive brand value: report
Published on 02/01/2026 at 20:25, 7 hours 36 minutes ago WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 12 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 15 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 2 days 1 hour ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 18:40, 2 days 9 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 2 days 10 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 10 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 19 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
